Home Cart 0 Sign in  
X

[ CAS No. 6298-37-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 6298-37-9
Chemical Structure| 6298-37-9
Chemical Structure| 6298-37-9
Structure of 6298-37-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 6298-37-9 ]

Related Doc. of [ 6298-37-9 ]

Alternatived Products of [ 6298-37-9 ]

Product Details of [ 6298-37-9 ]

CAS No. :6298-37-9 MDL No. :MFCD00462821
Formula : C8H7N3 Boiling Point : -
Linear Structure Formula :- InChI Key :MSGRFBKVMUKEGZ-UHFFFAOYSA-N
M.W : 145.16 Pubchem ID :237859
Synonyms :
Chemical Name :Quinoxalin-6-amine

Calculated chemistry of [ 6298-37-9 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 43.94
TPSA : 51.8 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.55 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.1
Log Po/w (XLOGP3) : 0.9
Log Po/w (WLOGP) : 1.22
Log Po/w (MLOGP) : 0.26
Log Po/w (SILICOS-IT) : 1.26
Consensus Log Po/w : 0.95

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.98
Solubility : 1.52 mg/ml ; 0.0105 mol/l
Class : Very soluble
Log S (Ali) : -1.57
Solubility : 3.88 mg/ml ; 0.0267 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.95
Solubility : 0.164 mg/ml ; 0.00113 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.44

Safety of [ 6298-37-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 6298-37-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 6298-37-9 ]
  • Downstream synthetic route of [ 6298-37-9 ]

[ 6298-37-9 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 6639-87-8 ]
  • [ 6298-37-9 ]
YieldReaction ConditionsOperation in experiment
99% With hydrazine hydrate In methanol at 20℃; for 1 h; b.
Quinoxalin-6-amine
To a solution of 6-nitroquinoxaline (17.0 g, 0.097 mol) in MeOH (500 mL) was added hydrazine hydrate (19.4 g, 0.39 mol) and Raney Ni (2.0 g).
The mixture was stirred at room temperature for 1 h.
The mixture was then filtered, and the filtrate was concentrated under reduce pressure to give quinoxalin-6-amine as a yellow solid (14.0 g, yield 99percent). ESI MS: m/z 146.1 [M+H]+.
98.75% With hydrazine hydrate In methanol at 0 - 20℃; for 2 h; [0170] To a solution of 6-nitroquinoxaline (2.2 g, 12.57 mmol, 1.0 eq) in MeOH, was added dropwise Ranney-Ni (0.7 mL) and hydrazine hydrate (5 mL) was added at 0 °C. The mixture was stirred for 2 h at RT. The mixture was filtered and washed with MeOH. The solid was dried under vacuo to give the product (1.8 g, yield: 98.75percent>). LC/MS: m/z (M++l) = 146. 42C. Preparation of N-methylquinoxalin-6-amine
82% With hydrogen In methanol for 4 h; Synthesis of 3-chloro-2-methvl-N-auinoxalin-6-vl-benzenesulfonamide, STX 957:; 6-aminoquinoxaline (KRB01083) :; To a solution of 6-nitroquinoxaline [24] (500 mg, 2.86 mmol) in methanol (20 mL) was added 10percent palladium on carbon (50 mg) and the mixture was stirred under 1 atm H2 for 4 h. The mixture was filtered through celite and the filtrate evaporated. The residue was passed through a silica plug and evaporated to afford 6-aminoquinoxaline as a yellow solid (342 mg, 82percent), single spot at Rf 0.32 (ethyl acetate).'H NMR (CDCI3) : 8 8.65 (1H, d, J= 1.7 Hz), 8.55 (1H, d, J=1.7 Hz), 7.87 (1H, d, J=8. 9 Hz), 7.18 (1H, dd, J=8.9, 2.5 Hz), 7.13 (1H, d, J=2.5 Hz), 4.20 (2H, br. s,-NH2) [25].
Reference: [1] Patent: US2012/178748, 2012, A1, . Location in patent: Page/Page column 43
[2] Patent: WO2013/6792, 2013, A1, . Location in patent: Paragraph 0170
[3] Patent: WO2005/42513, 2005, A1, . Location in patent: Page/Page column 71
[4] Heterocycles, 2007, vol. 72, p. 353 - 361
[5] Journal of Medicinal Chemistry, 2016, vol. 59, # 13, p. 6169 - 6186
[6] European Journal of Organic Chemistry, 2005, # 22, p. 4870 - 4878
[7] Tetrahedron Letters, 2010, vol. 51, # 41, p. 5402 - 5405
[8] Tetrahedron, 1990, vol. 46, # 6, p. 2089 - 2096
[9] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 6, p. 3255 - 3260
[10] Journal of the American Chemical Society, 1959, vol. 81, p. 6297,6300
[11] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 4, p. 815 - 820
[12] Synthesis (Germany), 2016, vol. 48, # 19, p. 3232 - 3240
  • 2
  • [ 5448-43-1 ]
  • [ 6298-37-9 ]
Reference: [1] Organic Letters, 2015, vol. 17, # 23, p. 5934 - 5937
[2] Angewandte Chemie - International Edition, 2015, vol. 54, # 12, p. 3773 - 3777[3] Angew. Chem., 2015, vol. 127, # 12, p. 3844 - 3848,5
[4] Angewandte Chemie - International Edition, 2015, vol. 54, # 12, p. 3768 - 3772[5] Angew. Chem., 2015, vol. 127, # 12, p. 3839 - 3843,5
[6] Organic Letters, 2014, vol. 16, # 17, p. 4388 - 4391
  • 3
  • [ 615-47-4 ]
  • [ 6298-37-9 ]
Reference: [1] Patent: US6323204, 2001, B1,
[2] Patent: US5373010, 1994, A,
[3] Patent: US5077292, 1991, A,
[4] Patent: US5552403, 1996, A,
[5] Patent: US5231096, 1993, A,
[6] Patent: US5021416, 1991, A,
  • 4
  • [ 50998-17-9 ]
  • [ 6298-37-9 ]
Reference: [1] Organic Letters, 2017, vol. 19, # 11, p. 2809 - 2812
[2] Organic Letters, 2013, vol. 15, # 14, p. 3734 - 3737
  • 5
  • [ 50998-18-0 ]
  • [ 6298-37-9 ]
Reference: [1] Organic Letters, 2017, vol. 19, # 11, p. 2809 - 2812
  • 6
  • [ 99-56-9 ]
  • [ 6298-37-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 4, p. 815 - 820
[2] Patent: US2012/178748, 2012, A1,
[3] Patent: WO2013/6792, 2013, A1,
[4] Journal of Medicinal Chemistry, 2016, vol. 59, # 13, p. 6169 - 6186
[5] Synthesis (Germany), 2016, vol. 48, # 19, p. 3232 - 3240
  • 7
  • [ 6639-87-8 ]
  • [ 131543-46-9 ]
  • [ 99-56-9 ]
  • [ 6298-37-9 ]
Reference: [1] Patent: US2003/195201, 2003, A1,
  • 8
  • [ 97-02-9 ]
  • [ 6298-37-9 ]
Reference: [1] Russian Journal of General Chemistry, 2004, vol. 74, # 3, p. 428 - 437
[2] Chemische Berichte, 1886, vol. 19, p. 1254[3] Justus Liebigs Annalen der Chemie, 1887, vol. 237, p. 345
[4] Chemische Berichte, 1886, vol. 19, p. 1254[5] Justus Liebigs Annalen der Chemie, 1887, vol. 237, p. 345
  • 9
  • [ 67-56-1 ]
  • [ 130130-97-1 ]
  • [ 6298-37-9 ]
  • [ 130130-98-2 ]
Reference: [1] Tetrahedron, 1990, vol. 46, # 6, p. 2089 - 2096
  • 10
  • [ 18381-20-9 ]
  • [ 615-71-4 ]
  • [ 6298-37-9 ]
Reference: [1] Russian Journal of General Chemistry, 2004, vol. 74, # 3, p. 428 - 437
  • 11
  • [ 131543-46-9 ]
  • [ 615-71-4 ]
  • [ 6298-37-9 ]
Reference: [1] Chemische Berichte, 1886, vol. 19, p. 1254[2] Justus Liebigs Annalen der Chemie, 1887, vol. 237, p. 345
  • 12
  • [ 176325-13-6 ]
  • [ 6298-37-9 ]
Reference: [1] Doklady Chemistry, 1999, vol. 368, # 4-6, p. 225 - 227
  • 13
  • [ 131543-46-9 ]
  • [ 7732-18-5 ]
  • [ 615-71-4 ]
  • [ 6298-37-9 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1887, vol. 237, p. 339[2] Justus Liebigs Annalen der Chemie, 1896, vol. 292, p. 246
  • 14
  • [ 6298-37-9 ]
  • [ 50358-63-9 ]
Reference: [1] Patent: US2004/266776, 2004, A1,
  • 15
  • [ 6298-37-9 ]
  • [ 50358-63-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 4, p. 815 - 820
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 6298-37-9 ]

Amines

Chemical Structure| 6640-47-7

[ 6640-47-7 ]

Quinoxaline-2,3-diamine

Similarity: 0.77

Chemical Structure| 580-19-8

[ 580-19-8 ]

Quinolin-7-amine

Similarity: 0.70

Chemical Structure| 50358-63-9

[ 50358-63-9 ]

6-Amino-5-bromoquinoxaline

Similarity: 0.67

Chemical Structure| 655-86-7

[ 655-86-7 ]

Phenazine-2,3-diamine

Similarity: 0.67

Chemical Structure| 1628557-04-9

[ 1628557-04-9 ]

Isoquinolin-3-ylmethanamine hydrochloride

Similarity: 0.66

Related Parent Nucleus of
[ 6298-37-9 ]

Quinoxalines

Chemical Structure| 13708-12-8

[ 13708-12-8 ]

5-Methylquinoxaline

Similarity: 0.86

Chemical Structure| 6344-72-5

[ 6344-72-5 ]

6-Methylquinoxaline

Similarity: 0.86

Chemical Structure| 6640-47-7

[ 6640-47-7 ]

Quinoxaline-2,3-diamine

Similarity: 0.77

Chemical Structure| 1448-87-9

[ 1448-87-9 ]

2-Chloroquinoxaline

Similarity: 0.75

Chemical Structure| 17635-21-1

[ 17635-21-1 ]

2,3,6-Trimethylquinoxaline

Similarity: 0.75